4//SEC Filing
Sims Andrew John Hugh MacIntyre 4
Accession 0001193125-26-000966
CIK 0001095981other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:30 PM ET
Size
7.1 KB
Accession
0001193125-26-000966
Insider Transaction Report
Form 4
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-01+38,323→ 106,461 total - Exercise/Conversion
Restricted Stock Units
2026-01-01−38,323→ 383,232 totalExercise: $0.00→ Common Stock (38,323 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
- [F2]Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.
Documents
Issuer
PLUS THERAPEUTICS, INC.
CIK 0001095981
Entity typeother
Related Parties
1- filerCIK 0001802687
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:30 PM ET
- Size
- 7.1 KB